Blair Barton, MD
Otolaryngology · Philadelphia, PANPI 1033538061
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,871 of the $6,026 with a category attached, or 80.8%. 13 manufacturers reported payments, led by Stryker at 29.1% of the total. 2025 is the largest year on record at $1,929, more than ten times the $142 reported in 2020.
Across 54 payments — averaging $111.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$2K
- 3-d Matrix, Inc.$981
- Integra Lifesciences Corporation$498
- Acclarent, Inc$464
- Regeneron$140
- plus $584 from 7 others
What the payments were for
- Consulting fees$601%
- Travel & lodging$1,09618%
- Food & beverage$4,87181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $1,756 |
| Medtronic | 21 | $1,604 |
| 3-d Matrix, Inc. | 2 | $981 |
| Integra Lifesciences Corporation | 5 | $498 |
| Acclarent, Inc | 3 | $464 |
| Regeneron | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 1 | $134 |
| Organogenesis Inc. | 3 | $130 |
| Sanofi | 1 | $126 |
| Aerin Medical Inc. | 1 | $125 |
| Kerecis Limited | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| GSK | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$1,096
- Acclarent Aera$581
- DUPIXENT$525
- PROPEL$519
- TruDi Nav Cable$464
- STEALTHSTATION S8 PLATFORM$389
- Inspira Air$371
- TruDi Probe$371
- PTEYE PARATHYROID DETECTION SYSTEM$306
- RELIEVA SPINPLUS NAV$265
- SCOPIS ENT$145
- NSE - SONOPET$142
- N/A$130
- VIVAER STYLUS$125
- RHINAER STYLUS$125
- FUSION$117
How this compares
$6,026 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 20 | $2,690 |
| Azelastine Hcl | 24 | $503 |
| Fluticasone Propionate | 35 | $355 |
| Pantoprazole Sodium | 42 | $299 |
| Doxycycline Hyclate | 25 | $191 |
| Levocetirizine Dihydrochloride | 19 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $119 |
| Levofloxacin | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Philadelphia
- Nancy SnydermanPhiladelphia$4.5M
- David KennedyPhiladelphia$603K
- James PalmerPhiladelphia$331K
- Mathew NagorskyPhiladelphia$95K
- Noam CohenPhiladelphia$76K
- Nithin AdappaPhiladelphia$72K
- Steven CannadyPhiladelphia$33K
- David CognettiPhiladelphia$30K
- John KrousePhiladelphia$30K
- Soo AbboudPhiladelphia$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.